Search research articles
Contact Us
Filters
Showing results (121-130 of 170) with videos related to
Page
of 17
Sort By:
Urologic Oncology
|
January 9, 2010
Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?
Jay D Raman, Shahrokh F Shariat, Pierre I Karakiewicz, et al.
Urologic Oncology
|
February 11, 2020
Prognostic value of the systemic inflammation modified Glasgow prognostic score in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy: Results from a large multicenter international collaboration
Francesco Soria, Andrea Giordano, David D'Andrea, et al.
Urologic Oncology
|
October 8, 2024
The efficacy of adjuvant mitotane therapy and radiotherapy following adrenalectomy in patients with adrenocortical carcinoma: A systematic review and meta-analysis
Ichiro Tsuboi, Mehdi Kardoust Parizi, Akihiro Matsukawa, et al.
European Urology
|
July 8, 2008
Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy
Alexander Haese, Alexandre de la Taille, Hendrik van Poppel, et al.
BJU International
|
February 22, 2011
Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration
Ramy F Youssef, Shahrokh F Shariat, Yair Lotan, et al.
Urologic Oncology
|
March 4, 2022
The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis
Judith Stangl-Kremser, Gianluca Muto, Antonio Andrea Grosso, et al.
European Urology Oncology
|
October 25, 2024
Oncological Outcomes of Active Surveillance versus Surgery or Ablation for Patients with Small Renal Masses: A Systematic Review and Quantitative Analysis
Ichiro Tsuboi, Pawel Rajwa, Riccardo Campi, et al.
BJU International
|
March 17, 2010
The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?
Guillaume Ploussard, Alexander Haese, Hendrik Van Poppel, et al.
The Journal of Urology
|
July 21, 2009
Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration
Nicholas J Hellenthal, Shahrokh F Shariat, Vitaly Margulis, et al.
World Journal of Urology
|
June 9, 2016
HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC)
Francesco Soria, Marco Moschini, Andrea Haitel, et al.
Page
of 17
Search research articles
Search
Showing results (121-130 of 170) with videos related to
Sort By:
Page
of 17
Urologic Oncology
|
January 9, 2010
Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?
Jay D Raman, Shahrokh F Shariat, Pierre I Karakiewicz, et al.
Urologic Oncology
|
February 11, 2020
Prognostic value of the systemic inflammation modified Glasgow prognostic score in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy: Results from a large multicenter international collaboration
Francesco Soria, Andrea Giordano, David D'Andrea, et al.
Urologic Oncology
|
October 8, 2024
The efficacy of adjuvant mitotane therapy and radiotherapy following adrenalectomy in patients with adrenocortical carcinoma: A systematic review and meta-analysis
Ichiro Tsuboi, Mehdi Kardoust Parizi, Akihiro Matsukawa, et al.
European Urology
|
July 8, 2008
Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy
Alexander Haese, Alexandre de la Taille, Hendrik van Poppel, et al.
BJU International
|
February 22, 2011
Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration
Ramy F Youssef, Shahrokh F Shariat, Yair Lotan, et al.
Urologic Oncology
|
March 4, 2022
The impact of lymphovascular invasion in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma: An extensive updated systematic review and meta-analysis
Judith Stangl-Kremser, Gianluca Muto, Antonio Andrea Grosso, et al.
European Urology Oncology
|
October 25, 2024
Oncological Outcomes of Active Surveillance versus Surgery or Ablation for Patients with Small Renal Masses: A Systematic Review and Quantitative Analysis
Ichiro Tsuboi, Pawel Rajwa, Riccardo Campi, et al.
BJU International
|
March 17, 2010
The prostate cancer gene 3 (PCA3) urine test in men with previous negative biopsies: does free-to-total prostate-specific antigen ratio influence the performance of the PCA3 score in predicting positive biopsies?
Guillaume Ploussard, Alexander Haese, Hendrik Van Poppel, et al.
The Journal of Urology
|
July 21, 2009
Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration
Nicholas J Hellenthal, Shahrokh F Shariat, Vitaly Margulis, et al.
World Journal of Urology
|
June 9, 2016
HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC)
Francesco Soria, Marco Moschini, Andrea Haitel, et al.
Page
of 17